BiotechTube

alglucosidase alfa + alglucosidase alfa

ApprovedTerminated
0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Pompe Disease (Infantile-Onset)

Conditions

Pompe Disease (Infantile-Onset), Glycogen Storage Disease Type II (GSD II), Glycogenosis 2, Acid Maltase Deficiency

Trial Timeline

Aug 1, 2012 → Dec 1, 2014

NCT ID
NCT01597596

About alglucosidase alfa + alglucosidase alfa

alglucosidase alfa + alglucosidase alfa is a approved stage product being developed by Sanofi for Pompe Disease (Infantile-Onset). The current trial status is terminated. This product is registered under clinical trial identifier NCT01597596. Target conditions include Pompe Disease (Infantile-Onset), Glycogen Storage Disease Type II (GSD II), Glycogenosis 2.

What happened to similar drugs?

9 of 16 similar drugs in Pompe Disease (Infantile-Onset) were approved

Approved (9) Terminated (3) Active (6)
✅alglucosidase alfaSanofiApproved
✅alglucosidase alfaSanofiApproved
✅Alglucosidase alfaSanofiApproved
✅alglucosidase alfaSanofiApproved
✅alglucosidase alfaSanofiApproved
✅Myozyme® (alglucosidase alfa) + Myozyme® (alglucosidase alfa)SanofiApproved
✅ALGLUCOSIDASE ALFASanofiApproved

Hype Score Breakdown

Clinical
20
Activity
0
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01597596ApprovedTerminated

Competing Products

20 competing products in Pompe Disease (Infantile-Onset)

See all competitors
ProductCompanyStageHype Score
S-606001 + PlaceboShionogiPhase 2
42
alglucosidase alfaSanofiApproved
43
GZ402666SanofiPhase 1
29
alglucosidase alfa + PlaceboSanofiPhase 3
40
alglucosidase alfaSanofiApproved
43
glucosidase alfaSanofiPre-clinical
26
Alglucosidase alfaSanofiApproved
35
Avalglucosidase AlfaSanofiPhase 2
35
alglucosidase alfaSanofiApproved
43
MyozymeSanofiPhase 3
40
alglucosidase alfaSanofiApproved
43
alglucosidase alfaSanofiPre-clinical
26
Avalglucosidase alfa (GZ402666) + Alglucosidase alfa (GZ419829)SanofiPhase 3
40
Myozyme® (alglucosidase alfa) + Myozyme® (alglucosidase alfa)SanofiApproved
35
ALGLUCOSIDASE ALFASanofiApproved
43
Avalglucosidase alfa (GZ402666) + Alglucosidase alfa (GZ419829)SanofiPhase 2
39
MyozymeSanofiPhase 2
35
MyozymeSanofiPhase 2
35
recombinant human acid alpha-glucosidase (rhGAA)SanofiPhase 2
35
Alglucosidase Alfa + Methotrexate + RituximabSanofiApproved
43